Ebrahim Variava to Double-Blind Method
This is a "connection" page, showing publications Ebrahim Variava has written about Double-Blind Method.
Connection Strength
0,038
-
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial. Lancet Respir Med. 2019 03; 7(3):249-259.
Score: 0,038